Free Trial
NASDAQ:VRAYQ

ViewRay (VRAYQ) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3,000 shs
Average Volume
435,785 shs
Market Capitalization
$18,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About ViewRay

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado. On July 16, 2023, ViewRay, Inc., alongwith its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. On October 26, 2023, the voluntary petition of ViewRay , Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on July 16, 2023.

VRAYQ Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive VRAYQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ViewRay and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:VRAYQ
Employees
295
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$102.21 million
Book Value
$0.45 per share

Miscellaneous

Free Float
178,817,000
Market Cap
$18,000.00
Optionable
Optionable
Beta
0.87
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Paul Ziegler Jr. (Age 50)
    J.D., President, CEO & Director
    Comp: $978.93k
  • Dr. James F. Dempsey Ph.D. (Age 53)
    Founder & Chief Scientific Officer
    Comp: $523.09k
  • Mr. Jacob Edward Signoriello
    Interim Chief Financial Officer
  • Drew Hill
    Senior Vice President of Operations & Development
  • Matt Harrison
    Director of Investor Relations
  • Mr. Sanket Shah J.D.
    Senior VP & General Counsel
  • Karen Hackstaff
    Vice President of Marketing
  • Ms. Julianne Mast
    Vice President of Human Resources
  • Dr. Martin Fuss M.D.
    Ph.D., Chief Medical Officer
  • Mr. Adam Podbelski
    Senior Vice President of Commercial Operations

VRAYQ Stock Analysis - Frequently Asked Questions

How do I buy shares of ViewRay?

Shares of VRAYQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:VRAYQ) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners